Fasedienol（Cat No.:I045109）is an investigational neuroactive nasal spray targeting the intranasal amygdala pathway to treat social anxiety disorder (SAD). It modulates activity at the neurosteroid-sensitive GABA<sub>A</sub> receptors, promoting anxiolytic effects without systemic sedation or dependence risks associated with benzodiazepines. Administered intranasally, Fasedienol acts rapidly to reduce anxiety symptoms during social interactions. It offers a novel, non-systemic approach to managing acute anxiety episodes with minimal side effects. Fasedienol is being evaluated for its efficacy, safety, and fast onset of action. Supplied for research on neurosteroid modulation and anxiety therapeutics.